UA36813A - preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5) - Google Patents

preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5)

Info

Publication number
UA36813A
UA36813A UA2000020760A UA200020760A UA36813A UA 36813 A UA36813 A UA 36813A UA 2000020760 A UA2000020760 A UA 2000020760A UA 200020760 A UA200020760 A UA 200020760A UA 36813 A UA36813 A UA 36813A
Authority
UA
Ukraine
Prior art keywords
treatment
radiophobia
neurosises
intimate
lon
Prior art date
Application number
UA2000020760A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Євген Степанович Товстуха
евгений Степанович Товстуха
Петро Євгенович Товстуха
Петр Евгеньевич Товстуха
Original Assignee
Євген Степанович Товстуха
евгений Степанович Товстуха
Петро Євгенович Товстуха
Петр Евгеньевич Товстуха
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Євген Степанович Товстуха, евгений Степанович Товстуха, Петро Євгенович Товстуха, Петр Евгеньевич Товстуха filed Critical Євген Степанович Товстуха
Priority to UA2000020760A priority Critical patent/UA36813A/en
Publication of UA36813A publication Critical patent/UA36813A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to chamical and pharmaceutical industry and medicine and concerns herb preparations possessing calming action. The proposed preparation allows not only to expand an arsenal of herb preparations for preventing and treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia, but also to increase efficiency of treatment with natural plant components. The proposed preparation contains hawthorn, mint, valerian, hop and yarrow herb.
UA2000020760A 2000-02-11 2000-02-11 preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5) UA36813A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000020760A UA36813A (en) 2000-02-11 2000-02-11 preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000020760A UA36813A (en) 2000-02-11 2000-02-11 preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5)

Publications (1)

Publication Number Publication Date
UA36813A true UA36813A (en) 2001-04-16

Family

ID=74182501

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000020760A UA36813A (en) 2000-02-11 2000-02-11 preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5)

Country Status (1)

Country Link
UA (1) UA36813A (en)

Similar Documents

Publication Publication Date Title
AP9801392A0 (en) Concentrated antibody preparation.
ATE83374T1 (en) NEW GALENIC FORM OF FENOFIBRATE.
AR020717A1 (en) THERAPEUTICALLY ACTIVE PROTEINS IN PLANTS.
ATE211907T1 (en) OSMOTIC DRUG RELEASE SYSTEM
ATE146360T1 (en) FREEZE-DRIED DROPS CONTAINING GONADOTROPIN
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
ATE224717T1 (en) ORAL MEDICINAL PREPARATIONS CONTAINING A BENZHYDRYLPIPERAZINE AND A CYCLODEXTRIN
ATE202931T1 (en) MEDICINAL PREPARATIONS CONTAINING TAXAN DERIVATIVES
DE69919533D1 (en) PROTEIN-BASED MEDICINAL PRODUCTS
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
TR200100637T2 (en) New natural product derivatives
DE60013526D1 (en) Composition containing compounds with adrenergic activity and herbal extracts from Crataegus and Gingko for the treatment of overweight and obesity
EP0744176A3 (en) Methods for inhibiting bone loss
UA36813A (en) preparation for treatment of intimate neurosises, stressful states, hypertonic disease, radiophobia (LON-5)
ATE347886T1 (en) MEDICINAL PREPARATIONS CONTAINING PACLITAXEL ENCLOSED IN NANOPARTICLES OF POLYMERIC MICELLARS
ATE238034T1 (en) FLAVOR MASKING OF BAD-TASTING FORMULATIONS
ATE88350T1 (en) DRUG.
MD1473G2 (en) Antiherpetic remedy
CU23077A1 (en) VACCINE COMPOSITION CONTAINING TRANSFORMING GROWTH FACTOR (TGF-ALFA). ITS USE IN MALIGNAL DISEASE THERAPY
MX9202547A (en) PROCEDURE FOR OBTAINING ANTINEOPLASTIC ACTION COMPOSITIONS AND SUBSTANCES, PRODUCTS OBTAINED THROUGH THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING SUCH ANTINEOPLASTIC ACTION SUBSTANCES
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
HUP0100634A2 (en) Pharmaceutical preparations comprising pentaerytritol tetranitrate
Mironov Session of the department of medical ecology, biotechnology, economics of medicine and industry of RAMTN
IE883402L (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
Meyers Effectiveness vs. efficacy of antidepressants for the treatment of late-life depression: introduction to a retrospective chart review of antidepressant use, effectiveness, and adverse effects in adults age 70 and older